What Farallon Capital Management LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 909661 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 13.6M |
| −0.4% |
| $2.5B |
| 11.7% |
EAElectronic Arts Inc. | 7.9M | New | $1.6B | 7.5% |
BBIOBridgeBio Pharma, Inc. | 10.7M | +14.7% | $800.1M | 3.7% |
PTGXProtagonist Therapeutics, Inc | 6.3M | ±0% | $778.2M | 3.6% |
EXELExelixis, Inc. | 13.5M | +2.7% | $732.8M | 3.4% |
LQDALiquidia Corp | 8.4M | −3.4% | $666.9M | 3.1% |
AMZNAmazon Com Inc | 2.6M | −37.6% | $627.5M | 2.9% |
LNTHLantheus Holdings, Inc. | 5.6M | ±0% | $619.4M | 2.9% |
NTRANatera, Inc. | 2.2M | −30.8% | $602.2M | 2.8% |
UNHUnitedHealth Group Inc | 1.3M | −30.3% | $528.1M | 2.4% |
TMOThermo Fisher Scientific Inc. | 1M | +19.0% | $526M | 2.4% |
ROIVRoivant Sciences Ltd. | 14.3M | +47.9% | $506.4M | 2.3% |
AONAon plc | 1.4M | −45.0% | $458.6M | 2.1% |
BSXBoston Scientific Corp | 10.5M | +40.8% | $449M | 2.1% |
AVGOBroadcom Inc. | 1.2M | −35.3% | $435.1M | 2% |
MSFTMicrosoft Corp | 1.1M | −52.5% | $415.1M | 1.9% |
TNGXTango Therapeutics, Inc. | 12.3M | +35.0% | $383.8M | 1.8% |
KKRKKR & Co. Inc. | 4.1M | −11.8% | $378M | 1.7% |
SNPSSynopsys Inc | 829.6K | −31.6% | $370.1M | 1.7% |
BEAMBeam Therapeutics Inc. | 10.2M | +1.0% | $351.3M | 1.6% |
CRNXCrinetics Pharmaceuticals, Inc. | 9M | +7.8% | $336.4M | 1.6% |
GRALGRAIL, Inc. | 4.2M | +27.9% | $284.1M | 1.3% |
WABWestinghouse Air Brake Technologies Corp | 894.5K | −44.4% | $241.2M | 1.1% |
IMVTImmunovant, Inc. | 5.8M | +275.5% | $223.7M | 1% |
TWSTTwist Bioscience Corp | 2.1M | +49.6% | $219.8M | 1% |
AGIOAgios Pharmaceuticals, Inc. | 5.9M | +4.1% | $219.6M | 1% |
ARMKAramark | 3.6M | −40.9% | $206.3M | 1% |
BIDUBaidu, Inc. | 1.2M | +171.3% | $137.6M | 0.6% |
NVONovo Nordisk a S | 2.6M | +234.9% | $125.6M | 0.6% |
ACHCAcadia Healthcare Company, Inc. | 4.2M | +143.0% | $124.6M | 0.6% |
BTSGBrightSpring Health Services, Inc. | 1.7M | +7.2% | $120.8M | 0.6% |
AZNAstraZeneca PLC | 574K | +153.4% | $108.8M | 0.5% |
JNJJohnson & Johnson | 408K | +175.7% | $103.6M | 0.5% |
ISHARES TRISHARES SEMICDTRPut option | 130K | New | $83.3M | 0.4% |
STRATEGY INCNOTE 12/0 | 87.9M | +122.4% | $75.4M | 0.3% |
PBLSParabilis Medicines, Inc. | 2.4M | New | $64.8M | 0.3% |
NVSNovartis AG | 363K | New | $56.9M | 0.3% |
GHGuardant Health, Inc. | 322.2K | +3,927.5% | $48.3M | 0.2% |
VNET GROUP INCNOTE 2.000%10/0 | 45M | ±0% | $46.8M | 0.2% |
AVTXAvalo Therapeutics, Inc. | 2.5M | +172.7% | $46.2M | 0.2% |
JOYYJOYY Inc. | 699.2K | +20.9% | $46.1M | 0.2% |
ASMBAssembly Biosciences, Inc. | 1.6M | +30.7% | $44.1M | 0.2% |
ENTAEnanta Pharmaceuticals Inc | 2.4M | −15.8% | $35.3M | 0.2% |
MAZEMaze Therapeutics, Inc. | 1.1M | +197.0% | $33.1M | 0.2% |
| 400K | New | $28.4M | 0.1% |
MRKMerck & Co., Inc. | 199K | −44.9% | $25.6M | 0.1% |
WRBYWarby Parker Inc. | 828K | New | $25.1M | 0.1% |
PCSCFreenome, Inc. | 2.3M | ±0% | $24.5M | 0.1% |
KLRAKailera Therapeutics, Inc. | 1.1M | New | $24.2M | 0.1% |
RIORio Tinto PLC | 183.5K | +241.0% | $17.4M | 0.1% |
AXTAAxalta Coating Systems Ltd. | 478K | New | $16.4M | 0.1% |
ABVXAbivax S.A. | 122K | +6,000.0% | $16.3M | 0.1% |
VNETVNET Group, Inc. | 2M | +219.6% | $16M | 0.1% |
NTESNetEase, Inc. | 123.5K | −57.6% | $15.8M | 0.1% |
BIIBBiogen Inc. | 71K | New | $15.3M | 0.1% |
TSHATaysha Gene Therapies, Inc. | 2.3M | New | $15.3M | 0.1% |
MOBIMobia Medical, Inc. | 1.1M | New | $15.1M | 0.1% |
STRATEGY INCNOTE 2.250% 6/1 | 15M | New | $14.2M | 0.1% |
NERVMinerva Neurosciences, Inc. | 2.4M | ±0% | $13.1M | 0.1% |
ALMRAlamar Biosciences, Inc. | 462.9K | New | $12.5M | 0.1% |
ALVOAlvotech | 2.9M | +1,332.2% | $10.6M | 0.1% |
BBNXBeta Bionics, Inc. | 595K | −83.5% | $9.3M | 0.1% |
IFRXInflaRx N.V. | 3.3M | New | $7.4M | 0.1% |
SMGScotts Miracle-Gro Co | 88K | New | $6M | 0.1% |
WAYWaystar Holding Corp. | 264.9K | New | $5.4M | 0.1% |
BCBrunswick Corp | 61K | New | $5.1M | 0.1% |
GNTXGentex Corp | 199K | New | $5M | 0.1% |
IDXXIDEXX Laboratories Inc | 9K | New | $4.7M | 0.1% |
PRMEPrime Medicine, Inc. | 1.2M | ±0% | $4.6M | 0.1% |
CMCCOMMERCIAL METALS Co | 67K | New | $4.2M | 0.1% |
JATTJATT II Acquisition Corp. | 300K | New | $3.4M | 0.1% |
SGMTSagimet Biosciences Inc. | 415K | New | $3.2M | 0.1% |
STRATEGY INCNOTE 3/0 | 2.6M | New | $2.3M | 0.1% |
SMCSummit Midstream Corp | 58.2K | ±0% | $1.7M | 0.1% |
TEVATeva Pharmaceutical Industries Ltd | 40K | −88.7% | $1.4M | 0.1% |
RVMDWRevolution Medicines, Inc. | 120.1K | ±0% | $1.1M | 0.1% |
COGTCogent Biosciences, Inc. | 17K | ±0% | $657.9K | 0.1% |
ANNAWAleAnna, Inc. | 990K | ±0% | $297K | 0.1% |
ANNAAleAnna, Inc. | 78.4K | ±0% | $227.4K | 0.1% |
WELLWelltower Inc. | 1K | −99.5% | $227K | 0.1% |
SLDPWSolid Power, Inc. | 405.3K | ±0% | $41.4K | 0.1% |
BGLWWBlue Gold Ltd | 255.8K | −14.7% | $30.7K | 0.1% |
PACBPacific Biosciences of California, Inc. | 14.2K | −89.5% | $23.9K | 0.1% |
GERNGeron Corp | 14.4K | −66.5% | $18.4K | 0.1% |
NVNIWNvni Group Ltd | 375K | ±0% | $17.6K | 0.1% |
CGCCanopy Growth Corp | 18K | −40.0% | $17.1K | 0.1% |
RANIRani Therapeutics Holdings, Inc. | 20.7K | −73.5% | $15.7K | 0.1% |
BYNDBeyond Meat, Inc. | 19K | ±0% | $14.3K | 0.1% |
